TY - JOUR
T1 - Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus
AU - Minkoff, Howard L.
AU - Eisenberger-Matityahu, Debra
AU - Feldman, Joseph
AU - Burk, Robert
AU - Clarke, Lorraine
PY - 1999
Y1 - 1999
N2 - OBJECTIVE: Our purpose was to ascertain the prevalence, incidence, and predictors of gynecologic disorders among women infected with human immunodeficiency virus. STUDY DESIGN: We serially assessed 292 women infected with human immunodeficiency virus and 681 uninfected women. Outcomes were incidence and prevalence of sexually transmitted diseases, viral shedding, findings of Papanicolaou smears, fungal infections, and menstrual disorders. RESULTS: Women infected with the virus were more likely to have prevalent vulvovaginal candidiasis (odds ratio 1.80, 95% confidence interval 1.0-3.25, P = .05), oncogenic human papillomavirus (odds ratio 3.79, 95% confidence interval 2.43-5.91, P = .001), abnormal Papanicolaou smears (odds ratio 5.40, 95% confidence interval 3.35-8.78, P = .001), amenorrhea (4.8% vs 0%, P = .05), positive results on Treponema pallidum hemagglutination assay (odds ratio 1.83, 95% confidence interval 1.16-2.88, P= .01), infection with cytomegalovirus (odds ratio 4.2, 95% confidence interval 1.82-10.62, P = .001), and genital warts (odds ratio 6.93, 95% confidence interval 3.16- 16.30, P = .001) but were less likely to have Chlamydia trachomatis infection (odds ratio 0.28, 95% confidence interval 0.10-0.66, P = .01). Annual incidence rates among women infected with human immunodeficiency virus were 4.0% for candidiasis, 22.0% for oncogenic human papillomavirus, 11.4% for genital warts, 1.7% for infection with C trachomatis, 1.7% for infection with Neisseria gonorrhoeae, 10.3% for Trichomonas vaginalis, 1.1% for positive results on T pallidum hemagglutination assay, 7.4% for an abnormal Papanicolaou smear, and 10.9% for infection with herpes simplex virus. Overall, 46.9% had at least 1 incident condition. Women infected with human immunodeficiency virus were more likely to have incident oncogenic human papillomavirus infection (odds ratio 2.0, 95% confidence interval 1.01-3.8), abnormal Papanicolaou smears (odds ratio 7.76, 95% confidence interval 2.08- 42.8), and genital warts (odds ratio 9.32, 95% confidence interval 3.04- 38.0). Incidence and prevalence of sexually transmitted diseases and oncogenic human papillomavirus infection increased with increased CD4+ cell counts. CONCLUSIONS: Women infected with the human immunodeficiency virus are significantly more likely to have prevalent and incident gynecologic disorders but not disorders related to risk taking (eg, incident sexually transmitted diseases). The latter disorders increased in women with CD4+ cell counts >500 cells/mm3. Clinicians should be aware of these patterns so that they can provide appropriate evaluation and treatment of gynecologic disorders.
AB - OBJECTIVE: Our purpose was to ascertain the prevalence, incidence, and predictors of gynecologic disorders among women infected with human immunodeficiency virus. STUDY DESIGN: We serially assessed 292 women infected with human immunodeficiency virus and 681 uninfected women. Outcomes were incidence and prevalence of sexually transmitted diseases, viral shedding, findings of Papanicolaou smears, fungal infections, and menstrual disorders. RESULTS: Women infected with the virus were more likely to have prevalent vulvovaginal candidiasis (odds ratio 1.80, 95% confidence interval 1.0-3.25, P = .05), oncogenic human papillomavirus (odds ratio 3.79, 95% confidence interval 2.43-5.91, P = .001), abnormal Papanicolaou smears (odds ratio 5.40, 95% confidence interval 3.35-8.78, P = .001), amenorrhea (4.8% vs 0%, P = .05), positive results on Treponema pallidum hemagglutination assay (odds ratio 1.83, 95% confidence interval 1.16-2.88, P= .01), infection with cytomegalovirus (odds ratio 4.2, 95% confidence interval 1.82-10.62, P = .001), and genital warts (odds ratio 6.93, 95% confidence interval 3.16- 16.30, P = .001) but were less likely to have Chlamydia trachomatis infection (odds ratio 0.28, 95% confidence interval 0.10-0.66, P = .01). Annual incidence rates among women infected with human immunodeficiency virus were 4.0% for candidiasis, 22.0% for oncogenic human papillomavirus, 11.4% for genital warts, 1.7% for infection with C trachomatis, 1.7% for infection with Neisseria gonorrhoeae, 10.3% for Trichomonas vaginalis, 1.1% for positive results on T pallidum hemagglutination assay, 7.4% for an abnormal Papanicolaou smear, and 10.9% for infection with herpes simplex virus. Overall, 46.9% had at least 1 incident condition. Women infected with human immunodeficiency virus were more likely to have incident oncogenic human papillomavirus infection (odds ratio 2.0, 95% confidence interval 1.01-3.8), abnormal Papanicolaou smears (odds ratio 7.76, 95% confidence interval 2.08- 42.8), and genital warts (odds ratio 9.32, 95% confidence interval 3.04- 38.0). Incidence and prevalence of sexually transmitted diseases and oncogenic human papillomavirus infection increased with increased CD4+ cell counts. CONCLUSIONS: Women infected with the human immunodeficiency virus are significantly more likely to have prevalent and incident gynecologic disorders but not disorders related to risk taking (eg, incident sexually transmitted diseases). The latter disorders increased in women with CD4+ cell counts >500 cells/mm3. Clinicians should be aware of these patterns so that they can provide appropriate evaluation and treatment of gynecologic disorders.
KW - Gynecologic disorders
KW - Human immunodeficiency virus
KW - Women
UR - http://www.scopus.com/inward/record.url?scp=0032902078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032902078&partnerID=8YFLogxK
U2 - 10.1016/S0002-9378(99)70653-8
DO - 10.1016/S0002-9378(99)70653-8
M3 - Article
C2 - 10203650
AN - SCOPUS:0032902078
SN - 0002-9378
VL - 180
SP - 824
EP - 836
JO - American journal of obstetrics and gynecology
JF - American journal of obstetrics and gynecology
IS - 4
ER -